brimonidine tartrate has been researched along with Hyperpigmentation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, JY; Kim, BJ; Kim, MN; Lee, HW; Park, KY | 1 |
| Ahn, GR; Kim, BJ; Lee, SJ; Nam Kim, M; Park, KY; Seo, SB | 1 |
| Kim, HY; Kim, MS; Lee, JH; Lee, SK; Lee, UH; Suh, JH | 1 |
3 other study(ies) available for brimonidine tartrate and Hyperpigmentation
| Article | Year |
|---|---|
Brimonidine tartrate gel plus topical steroid for the prevention of laser therapy-related postinflammatory hyperpigmentation.
Topics: Administration, Cutaneous; Adrenergic alpha-2 Receptor Agonists; Anti-Inflammatory Agents; Brimonidine Tartrate; Dermatitis; Gels; Humans; Hyperpigmentation; Lasers, Solid-State; Lentigo; Male; Methylprednisolone; Middle Aged | 2018 |
Topical brimonidine-assisted laser treatment for the prevention of therapy-related erythema and hyperpigmentation.
Topics: Administration, Topical; Adolescent; Adrenergic alpha-2 Receptor Agonists; Brimonidine Tartrate; Erythema; Humans; Hyperpigmentation; Low-Level Light Therapy; Male; Middle Aged; Tattooing | 2019 |
A case of latanoprost-induced diffuse facial skin hyperpigmentation.
Topics: Administration, Cutaneous; Administration, Ophthalmic; Aged; Antihypertensive Agents; Biopsy; Brimonidine Tartrate; Dermatologic Agents; Drug Substitution; Face; Female; Glaucoma; Humans; Hyperpigmentation; Lasers, Solid-State; Latanoprost; Low-Level Light Therapy; Ophthalmic Solutions; Skin; Skin Pigmentation; Treatment Outcome | 2019 |